Andrea Califano will receive  $4,893,902 over five years from the National Cancer Institute for “Elucidating and Targeting tumor dependencies and drug resistance determinants at the single cell level”. The aims of the project are to elucidate Master Regulators representing non-oncogene dependencies of molecularly distinct malignant subpopulations coexisting in the same tumor to support novel combination and sequential therapy approaches.